Is there any evidence implying the use of a different criterion for protective anti-HBs titer after HBV vaccination in immunosuppressed patients?
作者信息
Hasanoğlu İmran, Güner Rahmet
机构信息
Department of Infectious Diseases and Clinical Microbiology, Yildirim Beyazit University School of Medicine, Ankara City Hospital, Ankara, Turkey.
出版信息
Turk J Gastroenterol. 2020 Apr;31(4):346-347. doi: 10.5152/tjg.2020.19040.
Abstract
摘要
相似文献
1
Is there any evidence implying the use of a different criterion for protective anti-HBs titer after HBV vaccination in immunosuppressed patients?是否有证据表明在免疫抑制患者中，乙肝疫苗接种后保护性抗-HBs滴度采用了不同的标准？
Turk J Gastroenterol. 2020 Apr;31(4):346-347. doi: 10.5152/tjg.2020.19040.
2
Hepatitis B Surface Antibody Titers at One and Two Years after Hepatitis B Virus Vaccination in Healthy Young Japanese Adults.健康日本年轻成年人接种乙肝疫苗后1年和2年时的乙肝表面抗体滴度
Intern Med. 2019 Aug 15;58(16):2349-2355. doi: 10.2169/internalmedicine.2231-18. Epub 2019 May 22.
3
Expression and detection of anti-HBs antibodies after hepatitis B virus infection or vaccination in the context of protective immunity.乙型肝炎病毒感染或接种疫苗后保护性免疫中的抗-HBs 抗体的表达和检测。
Arch Virol. 2019 Nov;164(11):2645-2658. doi: 10.1007/s00705-019-04369-9. Epub 2019 Aug 9.
4
Persistence of Immunity for Hepatitis B Virus among Heathcare Workers and Italian Medical Students 20 Years after Vaccination.乙型肝炎病毒免疫持久性：接种疫苗 20 年后医护人员和意大利医学生的情况
Int J Environ Res Public Health. 2019 Apr 29;16(9):1515. doi: 10.3390/ijerph16091515.
5
Active immunization for prevention of De novo hepatitis B virus infection after adult living donor liver transplantation with a hepatitis B core antigen-positive graft.使用乙型肝炎核心抗原阳性供肝进行成人活体肝移植后主动免疫预防新发性乙型肝炎病毒感染。
Liver Transpl. 2017 Oct;23(10):1266-1272. doi: 10.1002/lt.24814.
6
The Serum Anti-HBs Level Among Children Who Received Routine Hepatitis B Vaccination During Infancy in Mianyang City, China: A Cross-Sectional Study.中国绵阳市婴儿期接受常规乙肝疫苗接种儿童的血清抗-HBs水平：一项横断面研究
Viral Immunol. 2016 Jan-Feb;29(1):40-8. doi: 10.1089/vim.2015.0073. Epub 2015 Nov 13.
7
Predictive factors for anti-HBs status after 1 booster dose of hepatitis B vaccine.一剂乙肝疫苗加强免疫后抗-HBs状态的预测因素
Medicine (Baltimore). 2016 Sep;95(39):e5023. doi: 10.1097/MD.0000000000005023.
8
Hepatitis B virus serologic markers and anti-hepatitis B vaccination in patients with diabetes.糖尿病患者的乙型肝炎病毒血清学标志物及乙型肝炎疫苗接种情况
Med Sci Monit. 2002 Jul;8(7):CR516-9.
9
Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis.乙型肝炎相关肝硬化移植患者强化三重疗程乙肝疫苗接种失败
Hepatology. 2002 Jan;35(1):176-81. doi: 10.1053/jhep.2002.30278.
10
Hepatitis B Vaccination in Patients Receiving Oral Antiviral Therapy Without Hepatitis B Immunoglobulin After Liver Transplant.肝移植后接受口服抗病毒治疗且未使用乙肝免疫球蛋白患者的乙肝疫苗接种
Transplant Proc. 2018 Dec;50(10):3681-3688. doi: 10.1016/j.transproceed.2018.07.008. Epub 2018 Jul 7.
本文引用的文献
1
Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices.美国乙型肝炎病毒感染预防：免疫实践咨询委员会的建议。
MMWR Recomm Rep. 2018 Jan 12;67(1):1-31. doi: 10.15585/mmwr.rr6701a1.
2
Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report.免疫抑制治疗与乙型肝炎再激活风险：共识报告
Turk J Gastroenterol. 2018 May;29(3):259-269. doi: 10.5152/tjg.2018.18263.
3
Hepatitis B vaccines: WHO position paper – July 2017.乙型肝炎疫苗：世界卫生组织立场文件 – 2017年7月
Wkly Epidemiol Rec. 2017 Jul 7;92(27):369-92.
4
Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions.与免疫抑制及生物调节剂治疗相关的乙型肝炎再激活：当前概念、管理策略及未来方向
Gastroenterology. 2017 May;152(6):1297-1309. doi: 10.1053/j.gastro.2017.02.009. Epub 2017 Feb 20.
5
Role of surface antibody in hepatitis B reactivation in patients with resolved infection and hematologic malignancy: A meta-analysis.表面抗体在已治愈感染和血液系统恶性肿瘤患者乙肝再激活中的作用：一项荟萃分析。
Hepatology. 2017 Aug;66(2):379-388. doi: 10.1002/hep.29082. Epub 2017 Jun 22.
6
American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.美国胃肠病学会关于免疫抑制药物治疗期间预防和治疗乙型肝炎病毒再激活的技术审查
Gastroenterology. 2015 Jan;148(1):221-244.e3. doi: 10.1053/j.gastro.2014.10.038. Epub 2014 Oct 31.
7
American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.美国胃肠病学会关于免疫抑制药物治疗期间预防和治疗乙型肝炎病毒再激活的指南。
Gastroenterology. 2015 Jan;148(1):215-9; quiz e16-7. doi: 10.1053/j.gastro.2014.10.039. Epub 2014 Oct 31.
8
Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune-suppressing and anticancer drugs: just the tip of the iceberg?美国食品药品监督管理局近期就免疫抑制药物和抗癌药物引发的乙型肝炎再激活发出警告：这只是冰山一角吗？
Hepatology. 2015 Feb;61(2):703-11. doi: 10.1002/hep.27609.
9
2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.2013 年美国感染病学会免疫功能低下宿主疫苗接种临床实践指南。
Clin Infect Dis. 2014 Feb;58(3):309-18. doi: 10.1093/cid/cit816.
Zotero 插件